Literature DB >> 30844014

[Frequent postural alterations in patients with different types of temporomandibular disorders].

Irene A Espinosa de Santillana1, Ariana García-Juárez2, Jaime Rebollo-Vázquez3, Ana K Ustarán-Aquino4.   

Abstract

OBJECTIVE: To describe postural alterations according to the type of temporomandibular disorder (TMD).
METHODS: Prior informed consent, 30 patients were included in the study, with a mean age of 27.4 years; 80% women, diagnosed with TMD based on Diagnostic Criteria (DC/ TTM) by a trained researcher in the clinic of the Faculty of Stomatology of the BUAP. Subsequently, a postural analysis (three views) was carried out at the facilities of the School of Physiotherapy of the BUAP using an acetate grid. The results were analyzed with descriptive statistics in the SPSS v20 program.
RESULTS: 16.7% of the patients presented muscular TMD, 36.7% joint TMD, and the rest combined TMD. The most common postural alterations were: high shoulder: 93.3%, pelvic tilt: 86.7%, and forward head posture: 83.3%. On average, the patients had between 4 and 5 postural changes. 100% of the patients ha alterations in the side view, while 50% of the patients with TMD of combined origin had alterations in the three views, as well as 45.5% of the patients with TMD of joint origin, and 60% of the patients with TMD of muscular origin.
CONCLUSIONS: TMD patients present postural changes, mainly forward head posture, pelvic tilt and high shoulder, with special involvement related to muscle and combined diagnosis.

Entities:  

Mesh:

Year:  2018        PMID: 30844014     DOI: 10.15446/rsap.V20n3.53529

Source DB:  PubMed          Journal:  Rev Salud Publica (Bogota)        ISSN: 0124-0064


  1 in total

1.  Cause-Effect Relationships between Painful TMD and Postural and Functional Changes in the Musculoskeletal System: A Preliminary Report.

Authors:  Adam Andrzej Garstka; Monika Brzózka; Aleksandra Bitenc-Jasiejko; Roman Ardan; Helena Gronwald; Piotr Skomro; Danuta Lietz-Kijak
Journal:  Pain Res Manag       Date:  2022-02-28       Impact factor: 3.037

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.